Bladder Cancer

Aims & Scope

Bladder Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the bladder and upper urinary tract.

The journal publishes research reports, reviews, short communications, and letters-to-the-editor.

The journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that expedites our fundamental understanding and improves treatment of tumors of the bladder and upper urinary tract.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting

  Citation: 179

  Authors: Seth P., David J., Katherine A., Keith S., William Y., François, Mattias, Francisco X.

• Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer

  Citation: 90

  Authors: Ryan L., Lewis J., Michael A., Kenneth G.

• Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCG

  Citation: 83

  Authors:

• A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer

  Citation: 76

  Authors: Jamie J., James C., Jayne S., Richard T., Douglas G.

• Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)

  Citation: 75

  Authors: Nicholas E., Jonathan

• Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines

  Citation: 72

  Authors: Tahlita C.M., Florus C., James C., Dan

• Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer

  Citation: 68

  Authors: Niv, Max, Meera R., Filippo, Takahiro, Alexander, Phillip M., Mark P., Trinity J.

• Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United States

  Citation: 66

  Authors: Matthew D., Sumanta Kumar, Shih-Wen, Sarika, Marko, Joseph, Christina, Christina, Guru

• Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients

  Citation: 64

  Authors: Joep J., Kees, Marloes, Hugh, Joost L.

• Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer

  Citation: 61

  Authors: Madhuri, Amanda Shuo, Kevin Yi Mi, Kash, Runhan, David M., D. Robert